JSCRX | NRGEX | JSCRX / NRGEX | |
Total Expense Ratio | 1.31 | 0.03 | 4,367% |
Annual Report Gross Expense Ratio | 1.56 | 0.69 | 226% |
Fund Existence | 21 years | 3 years | - |
Gain YTD | -6.684 | -5.861 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.97B | 9.11B | 33% |
Annual Yield % from dividends | 0.41 | 0.56 | 73% |
Returns for 1 year | 1.14 | -1.91 | -60% |
Returns for 3 years | 15.94 | 10.76 | 148% |
Returns for 5 years | 8.18 | N/A | - |
Returns for 10 years | -30.51 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ADNPX | 16.67 | 0.03 | +0.18% |
American Beacon ARK Transfmt Innov Inv | |||
RYHAX | 103.38 | -0.84 | -0.81% |
Rydex Health Care H | |||
LMGAX | 26.22 | -0.29 | -1.09% |
Lord Abbett Growth Opportunities A | |||
AEYGX | 33.61 | -0.49 | -1.44% |
American Century Equity Growth R5 | |||
LMGFX | 71.20 | -1.18 | -1.63% |
ClearBridge International Growth FI |